Clinical Trials Directory

Trials / Completed

CompletedNCT05829824

Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach

Connect Cancer Patients to Tobacco Cessation Care by Automated Interactive Outreach

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
400 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a multi-arm, randomized controlled, pilot study which will recruit cancer patients who have been seen by a UCSF Cancer Center-affiliated clinical department to evaluate the efficacy of "CareConnect". This is the first study to assess the efficacy CareConnect, a combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR) delivering cancer-targeted educational messages to support referral to smoking cessation resources for patients with cancer.

Detailed description

PRIMARY OBJECTIVE: I. To evaluate CareConnect's efficacy on referring patients to tobacco cessation resources. SECONDARY OBJECTIVE: I. To evaluate patients' acceptance of referrals. II. To evaluate the acceptability of CareConnect. EXPLORATORY OBJECTIVES: I. In-depth semi-structured qualitative interviews of 20 selectively chosen participants who completed the 3-month follow-up survey or finished the automated CareConnect or Auto-Reach call but may have refused to complete the 3-month follow-up survey (10 from each group). II. Smoking cessation with verification. OUTLINE: Eligible participants, identified through the Cancer Center Tobacco Registry will be randomized to either the Intervention or Control arm on a 1:1 ratio. Participants who complete the first call of CareConnect or AutoReach will be considered enrolled. Participants will complete a baseline assessment, a 3-month assessment, and have option to provide a saliva sample. For those who are selected to participate in an in-depth interview, this will take place within 1 month after the 3-month assessment. Data from the participants medical record may be accessed at 6 months post follow-up.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCareConnectA combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR)
OTHERAutoReachPhone call / SMS Text
PROCEDUREBiospecimen samplesOptional saliva sample

Timeline

Start date
2023-11-27
Primary completion
2025-05-07
Completion
2025-08-15
First posted
2023-04-26
Last updated
2026-02-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05829824. Inclusion in this directory is not an endorsement.